Citadel Advisors - BONE BIOLOGICS CORP ownership

BONE BIOLOGICS CORP's ticker is and the CUSIP is 098070303. A total of 5 filers reported holding BONE BIOLOGICS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of BONE BIOLOGICS CORP
ValueSharesWeighting
Q1 2022$30,00010,7410.00%
Other shareholders
BONE BIOLOGICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
JANE STREET GROUP, LLC 13,464$37,0000.00%
UBS Group AG 85$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Citadel Advisors 10,741$30,0000.00%
VANGUARD GROUP INC 33,461$93,0000.00%
View complete list of BONE BIOLOGICS CORP shareholders